-
1
-
-
25444513417
-
Atypical antipsychotics and the burden of disease
-
Simpson GM. Atypical antipsychotics and the burden of disease. Am J Manag Care. 2005;1(suppl 8):S235-S241.
-
(2005)
Am J Manag Care
, vol.1
, pp. S235-S241
-
-
Simpson, G.M.1
-
2
-
-
0032965694
-
The economic impact of schizophrenia
-
28-30
-
Rice DP. The economic impact of schizophrenia. J Clin Psychiatry. 1999; 60(suppl 1):4-6; 28-30.
-
(1999)
J Clin Psychiatry
, vol.60
, pp. 4-6
-
-
Rice, D.P.1
-
3
-
-
26644472427
-
The economic burden of schizophrenia in the United States in 2002
-
Wu EQ, Birnbaum HG, Shi L, et al. The economic burden of schizophrenia in the United States in 2002. J Clin Psychiatry. 2005;66:1122-1129.
-
(2005)
J Clin Psychiatry
, vol.66
, pp. 1122-1129
-
-
Wu, E.Q.1
Birnbaum, H.G.2
Shi, L.3
-
4
-
-
3042529588
-
Focus on antipsychotic polypharmacy: Evidence-based prescribing or prescribing-based evidence?
-
Stahl SM. Focus on antipsychotic polypharmacy: evidence-based prescribing or prescribing-based evidence? Int J Neuropsychopharmacol. 2004;7:113-116.
-
(2004)
Int J Neuropsychopharmacol
, vol.7
, pp. 113-116
-
-
Stahl, S.M.1
-
5
-
-
14744291781
-
Patterns and quality of treatment for patients with schizophrenia in routine psychiatric practice
-
West JC, Wilk JE, Olfson M, et al. Patterns and quality of treatment for patients with schizophrenia in routine psychiatric practice. Psychiatr Serv. 2005;56:283-291.
-
(2005)
Psychiatr Serv
, vol.56
, pp. 283-291
-
-
West, J.C.1
Wilk, J.E.2
Olfson, M.3
-
6
-
-
12944304694
-
Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000
-
Ganguly R, Kotzan JA, Miller LS, et al. Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000. J Clin Psychiatry. 2004;65:1377-1388.
-
(2004)
J Clin Psychiatry
, vol.65
, pp. 1377-1388
-
-
Ganguly, R.1
Kotzan, J.A.2
Miller, L.S.3
-
7
-
-
0242643663
-
Benchmarking the quality of schizophrenia pharmacotherapy: A comparison of the Department of Veterans Affairs and the private sector
-
Leslie DL, Rosenheck RA. Benchmarking the quality of schizophrenia pharmacotherapy: a comparison of the Department of Veterans Affairs and the private sector. J Ment Health Policy Econ. 2003;6:113-121.
-
(2003)
J Ment Health Policy Econ
, vol.6
, pp. 113-121
-
-
Leslie, D.L.1
Rosenheck, R.A.2
-
8
-
-
0035988515
-
Antipsychotic prescribing practices in the Veterans Healthcare Administration-New York metropolitan region
-
Weissman EM. Antipsychotic prescribing practices in the Veterans Healthcare Administration-New York metropolitan region. Schizophr Bull. 2002;28:31-42.
-
(2002)
Schizophr Bull
, vol.28
, pp. 31-42
-
-
Weissman, E.M.1
-
9
-
-
84861087821
-
Prevalence of concomitant oral antipsychotic drug use among patients treated with long-acting, intramuscular, antipsychotic medications
-
Aggarwal NK, Sernyak MJ, Rosenheck RA. Prevalence of concomitant oral antipsychotic drug use among patients treated with long-acting, intramuscular, antipsychotic medications. J Clin Psychopharmacol. 2012; 32:323-328.
-
(2012)
J Clin Psychopharmacol
, vol.32
, pp. 323-328
-
-
Aggarwal, N.K.1
Sernyak, M.J.2
Rosenheck, R.A.3
-
10
-
-
34247367267
-
Characteristics and use patterns of patients taking first-generation depot antipsychotics or oral antipsychotics for schizophrenia
-
Shi L, Ascher-Svanum H, Zhu B, et al. Characteristics and use patterns of patients taking first-generation depot antipsychotics or oral antipsychotics for schizophrenia. Psychiatr Serv. 2007;58:482-488.
-
(2007)
Psychiatr Serv
, vol.58
, pp. 482-488
-
-
Shi, L.1
Ascher-Svanum, H.2
Zhu, B.3
-
11
-
-
33750039955
-
Annual prevalence of diagnosed schizophrenia in the USA: A claims data analysis approach
-
Wu EQ, Shi L, Birnbaum H, et al. Annual prevalence of diagnosed schizophrenia in the USA: a claims data analysis approach. Psychol Med. 2006;36:1535-1540.
-
(2006)
Psychol Med
, vol.36
, pp. 1535-1540
-
-
Wu, E.Q.1
Shi, L.2
Birnbaum, H.3
-
12
-
-
33846468943
-
A checklist for medication compliance and persistence studies using retrospective databases
-
Peterson A, Nau D, Cramer J, et al. A checklist for medication compliance and persistence studies using retrospective databases. Value Health. 2007;10:3-12.
-
(2007)
Value Health
, vol.10
, pp. 3-12
-
-
Peterson, A.1
Nau, D.2
Cramer, J.3
-
13
-
-
55349139334
-
When is antipsychotic polypharmacy supported by research evidence? Implications for QI
-
Gören JL, Parks JJ, Ghinassi FA, et al. When is antipsychotic polypharmacy supported by research evidence? Implications for QI. Jt Comm J Qual Patient Saf. 2008;34:571-582.
-
(2008)
Jt Comm J Qual Patient Saf
, vol.34
, pp. 571-582
-
-
Gören, J.L.1
Parks, J.J.2
Ghinassi, F.A.3
-
15
-
-
11244278062
-
Challenges to evidence-based medicine: A comparison of patients and treatments in randomized controlled trials with patients and treatments in a practice research network
-
Zarin DA, Young JL, West JC. Challenges to evidence-based medicine: a comparison of patients and treatments in randomized controlled trials with patients and treatments in a practice research network. Soc Psychiatry Psychiatr Epidemiol. 2005;40:27-35.
-
(2005)
Soc Psychiatry Psychiatr Epidemiol
, vol.40
, pp. 27-35
-
-
Zarin, D.A.1
Young, J.L.2
West, J.C.3
-
16
-
-
1642283731
-
Practice guideline for the treatment of patients with schizophrenia, second edition
-
Lehman AF, Lieberman JA, Dixon LB, et al. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry. 2004;161(suppl 2):1-56.
-
(2004)
Am J Psychiatry
, vol.161
, pp. 1-56
-
-
Lehman, A.F.1
Lieberman, J.A.2
Dixon, L.B.3
-
17
-
-
1542270909
-
The Schizophrenia Patient Outcomes Research Team (PORT): Updated treatment recommendations 2003
-
Lehman AF, Kreyenbuhl J, Buchanan RW, et al. The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2003. Schizophr Bull. 2004;30:193-217.
-
(2004)
Schizophr Bull
, vol.30
, pp. 193-217
-
-
Lehman, A.F.1
Kreyenbuhl, J.2
Buchanan, R.W.3
|